442 related articles for article (PubMed ID: 17428871)
21. Dimerization regulates both deaminase-dependent and deaminase-independent HIV-1 restriction by APOBEC3G.
Morse M; Huo R; Feng Y; Rouzina I; Chelico L; Williams MC
Nat Commun; 2017 Sep; 8(1):597. PubMed ID: 28928403
[TBL] [Abstract][Full Text] [Related]
22. Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H.
Soros VB; Yonemoto W; Greene WC
PLoS Pathog; 2007 Feb; 3(2):e15. PubMed ID: 17291161
[TBL] [Abstract][Full Text] [Related]
23. Induction of heat-shock protein 70 by prostaglandin A₁ inhibits HIV-1 Vif-mediated degradation of APOBEC3G.
Sugiyama R; Abe M; Nishitsuji H; Murakami Y; Takeuchi H; Takaku H
Antiviral Res; 2013 Sep; 99(3):307-11. PubMed ID: 23831493
[TBL] [Abstract][Full Text] [Related]
24. New insights into the role of Vif in HIV-1 replication.
Schröfelbauer B; Yu Q; Landau NR
AIDS Rev; 2004; 6(1):34-9. PubMed ID: 15168739
[TBL] [Abstract][Full Text] [Related]
25. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.
Zhang H; Yang B; Pomerantz RJ; Zhang C; Arunachalam SC; Gao L
Nature; 2003 Jul; 424(6944):94-8. PubMed ID: 12808465
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host.
Argyris EG; Pomerantz RJ
Trends Microbiol; 2004 Apr; 12(4):145-8. PubMed ID: 15116720
[No Abstract] [Full Text] [Related]
27. Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.
Goila-Gaur R; Khan MA; Miyagi E; Kao S; Strebel K
Retrovirology; 2007 Aug; 4():61. PubMed ID: 17727729
[TBL] [Abstract][Full Text] [Related]
28. RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study.
Bernacchi S; Henriet S; Dumas P; Paillart JC; Marquet R
J Biol Chem; 2007 Sep; 282(36):26361-8. PubMed ID: 17609216
[TBL] [Abstract][Full Text] [Related]
29. Lentiviral Vif: viral hijacker of the ubiquitin-proteasome system.
Ehrlich ES; Yu XF
Int J Hematol; 2006 Apr; 83(3):208-12. PubMed ID: 16720549
[TBL] [Abstract][Full Text] [Related]
30. Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA.
Yang B; Chen K; Zhang C; Huang S; Zhang H
J Biol Chem; 2007 Apr; 282(16):11667-75. PubMed ID: 17272283
[TBL] [Abstract][Full Text] [Related]
31. The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules.
Kozak SL; Marin M; Rose KM; Bystrom C; Kabat D
J Biol Chem; 2006 Sep; 281(39):29105-19. PubMed ID: 16887808
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.
Liu B; Sarkis PT; Luo K; Yu Y; Yu XF
J Virol; 2005 Aug; 79(15):9579-87. PubMed ID: 16014920
[TBL] [Abstract][Full Text] [Related]
33. The viral infectivity factor (Vif) of HIV-1 unveiled.
Rose KM; Marin M; Kozak SL; Kabat D
Trends Mol Med; 2004 Jun; 10(6):291-7. PubMed ID: 15177194
[TBL] [Abstract][Full Text] [Related]
34. The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation.
Valera MS; de Armas-Rillo L; Barroso-González J; Ziglio S; Batisse J; Dubois N; Marrero-Hernández S; Borel S; García-Expósito L; Biard-Piechaczyk M; Paillart JC; Valenzuela-Fernández A
Retrovirology; 2015 Jun; 12():53. PubMed ID: 26105074
[TBL] [Abstract][Full Text] [Related]
35. Death by deamination: a novel host restriction system for HIV-1.
Goff SP
Cell; 2003 Aug; 114(3):281-3. PubMed ID: 12914693
[TBL] [Abstract][Full Text] [Related]
36. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication.
Zheng YH; Irwin D; Kurosu T; Tokunaga K; Sata T; Peterlin BM
J Virol; 2004 Jun; 78(11):6073-6. PubMed ID: 15141007
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 subtype variability in Vif derived from molecular clones affects APOBEC3G-mediated host restriction.
Lisovsky I; Schader SM; Sloan RD; Oliveira M; Coutsinos D; Bernard NF; Wainberg MA
Intervirology; 2013; 56(4):258-64. PubMed ID: 23689841
[TBL] [Abstract][Full Text] [Related]
38. DNA deamination mediates innate immunity to retroviral infection.
Harris RS; Bishop KN; Sheehy AM; Craig HM; Petersen-Mahrt SK; Watt IN; Neuberger MS; Malim MH
Cell; 2003 Jun; 113(6):803-9. PubMed ID: 12809610
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a replication-defective human immunodeficiency virus type 1 att site mutant that is blocked after the 3' processing step of retroviral integration.
Chen H; Engelman A
J Virol; 2000 Sep; 74(17):8188-93. PubMed ID: 10933731
[TBL] [Abstract][Full Text] [Related]
40. Recent insights into HIV-1 Vif.
Navarro F; Landau NR
Curr Opin Immunol; 2004 Aug; 16(4):477-82. PubMed ID: 15245742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
